Literature DB >> 11700197

Ménière's disease in childhood.

H Akagi1, K Yuen, Y Maeda, K Fukushima, S Kariya, Y Orita, Y Kataoka, T Ogawa, K Nishizaki.   

Abstract

We report 3 rare cases of Ménière's disease in children. In Case 1 and 3, vertigo, hearing loss and tinnitus recovered soon after medical therapy. In Case 2, however, vertigo recurred and the hearing level on the right side markedly deteriorated. The equal-loudness contours on three-dimensional audiogram showed that right-sided aggravated hearing loss fluctuated for 4 years at middle-and low-frequencies despite medication. Finally intratympanic injection of gentamicin sulfate was performed. The patient has had no definitive spell of vertigo after gentamicin therapy. At our department, the incidence of Ménière's disease in pediatric patients with vertigo was 2.9%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700197     DOI: 10.1016/s0165-5876(01)00576-6

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  4 in total

1.  Successful treatment of a child with definite Meniere's disease with the migraine regimen.

Authors:  Mehdi Abouzari; Arash Abiri; Hamid R Djalilian
Journal:  Am J Otolaryngol       Date:  2019-02-18       Impact factor: 1.808

Review 2.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

3.  Treatment of Menière's Disease.

Authors:  Jeffrey D Sharon; Carolina Trevino; Michael C Schubert; John P Carey
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

Review 4.  The Pharmacological Treatment of Pediatric Vertigo.

Authors:  Pasquale Viola; Gianmarco Marcianò; Alessandro Casarella; Davide Pisani; Alessia Astorina; Alfonso Scarpa; Elena Siccardi; Emanuele Basile; Giovambattista De Sarro; Luca Gallelli; Giuseppe Chiarella
Journal:  Children (Basel)       Date:  2022-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.